EP 1229921 A1 20020814 - HEPARANASE INHIBITORS FOR THE TREATMENT OF HEART FAILURE
Title (en)
HEPARANASE INHIBITORS FOR THE TREATMENT OF HEART FAILURE
Title (de)
HEPARANASE-INHIBITOREN ZUR BEHANDLUNG VON HERZINSUFFIZIENZ
Title (fr)
INHIBITEURS D'HEPARANASE UTILISES DANS LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE
Publication
Application
Priority
- DE 19955803 A 19991119
- EP 0011441 W 20001117
Abstract (en)
[origin: WO0135967A1] The invention relates to the use of heparanase inhibitors for the treatment of heart failure, especially congestive heart failure, and related indications, symptoms and/or dysfunctions such as peripheral edema, pulmonary and liver congestion, dyspnea, hydrothorax and abdominal dropsy. The invention also relates to a method for producing pharmaceutical agents used to treat heart failure.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/726 (2006.01); A61K 31/727 (2006.01); A61P 9/04 (2006.01); A61P 9/10 (2006.01)
CPC (source: EP)
A61K 31/00 (2013.01); A61K 31/702 (2013.01); A61K 31/726 (2013.01); A61K 31/727 (2013.01); A61P 9/04 (2017.12); A61P 9/10 (2017.12)
Citation (search report)
See references of WO 0135967A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0135967 A1 20010525; AU 1522101 A 20010530; DE 19955803 A1 20010523; EP 1229921 A1 20020814
DOCDB simple family (application)
EP 0011441 W 20001117; AU 1522101 A 20001117; DE 19955803 A 19991119; EP 00977548 A 20001117